fbpx Phase 1 RNL-186 Shows Promise in Leptomeningeal Metastases: Andrew Brenner, MD, PhD - Plus Therapeutics (PSTV)

Phase 1 RNL-186 Shows Promise in Leptomeningeal Metastases: Andrew Brenner, MD, PhD